Patents Assigned to Medifron DBT Inc.
  • COMPOUND HAVING INHIBITORY ACTIVITY AGAINST O-GLUSACASE AND USE THEREOF
    Publication number: 20240018135
    Abstract: The present invention relates to a novel compound having inhibitory activity against O-GlcNAcase and a use thereof.
    Type: Application
    Filed: November 19, 2021
    Publication date: January 18, 2024
    Applicant: MEDIFRON DBT INC.
    Inventors: Hee KIM, Hee Jin HA, Hye Min JU, Ki Sun ROH, Jae Hong IM, Jin Mi KANG, Minyoung Lee
  • Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II
    Patent number: 9771359
    Abstract: The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: September 26, 2017
    Assignee: Medifron DBT Inc.
    Inventors: Robert Frank-Foltyn, Christopher Habermann, Gregor Bahrenberg, Bernhard Lesch, Nils Damann, Klaus Schiene, Hannelore Stockhausen, Thomas Christoph, Sven Frormann, Derek Saunders, Jeewoo Lee